Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
cell therapy
Biotech
Zephyrm seeks Hong Kong IPO to fund phase 3 cell therapy trials
Zephyrm filed for an IPO to bankroll phase 3 trials of its cell therapy in a lung condition and graft-versus-host disease.
Nick Paul Taylor
Oct 2, 2024 8:19am
BMS pays Prime $110M to form T-cell therapy pact
Sep 30, 2024 7:18am
Achilles drops cell therapy program, braces for layoffs
Sep 19, 2024 9:24am
New cell therapy biotech emerges from the lab of George Church
Sep 19, 2024 6:30am
Carisma, Moderna expand cell therapy collab to autoimmune area
Sep 10, 2024 12:31pm
Fibroblast cell therapy toughens skin in small clinical trial
Sep 9, 2024 2:26pm